![Jayson Punwani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jayson Punwani
Direktor/Vorstandsmitglied bei
ArmaGen, Inc.
Profil
Jayson Punwani is the founder of Coho Therapeutics, Inc., founded in 2019.
Current jobs include Director at ArmaGen, Inc., Director at Palleon Pharmaceuticals, Inc., Director at Xilio Therapeutics LLC since 2020, and Managing Director at Abingworth LLP.
Former jobs include Director at Xilio Therapeutics, Inc., Director at StrideBio, Inc., Director at VelosBio, Inc., Principal at Pappas Capital LLC from 2011 to 2017, and Partner at Takeda Ventures, Inc. from 2017 to 2020.
Education includes a doctorate from the University of Utah, an undergraduate degree from The College of New Jersey, and an MBA from The University of North Carolina at Charlotte.
Aktive Positionen von Jayson Punwani
| Unternehmen | Position | Beginn |
|---|---|---|
ArmaGen, Inc.
 ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Direktor/Vorstandsmitglied | - |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Direktor/Vorstandsmitglied | - |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Direktor/Vorstandsmitglied | 02.03.2020 |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Jayson Punwani
| Unternehmen | Position | Ende |
|---|---|---|
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Private Equity Investor | 01.11.2020 |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Private-Equity-Analyst | 31.10.2017 |
Coho Therapeutics, Inc.
 Coho Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceuticals | Gründer | - |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Direktor/Vorstandsmitglied | - |
| XILIO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jayson Punwani
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
ArmaGen, Inc.
ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Health Technology |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Finance |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The College of New Jersey
 The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Ventures, Inc.
Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Finance |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
VelosBio, Inc.
VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Commercial Services |
Coho Therapeutics, Inc.
Coho Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceuticals | Health Technology |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Health Technology |
